Venture Capital

Pioneering clean beauty brand Indie Lee launches an affordable new line, Indie Lee Botanicals, exclusively at Whole Foods Market, making quality skincare accessible.

With $6.9M in total funding, the UMass spin-out is set to disrupt AR and AI markets with its durable, all-inorganic nano-imprinted optical components.

With new backing from One Six 8 Ventures, health tech firm Respiree accelerates its US and Canadian expansion of its FDA-cleared AI platform.

The Raine Group hires Credit Suisse veteran Anthony Kontoleon, signaling a major push to dominate TMT advisory ahead of an anticipated tech boom.

With new high-protein flavors, Forager Project is betting on a unique cashew-based recipe to win over consumers disappointed by other dairy-free options.

As smugglers take to the sea in high-tech subs, companies like Jeffs' Brands are betting on AI-driven underwater security to turn the tide.

With 43% YoY growth, Cato Networks is outpacing the SASE market. A new acquisition and key hires signal a deep focus on securing the AI era.

Kenai Therapeutics hires a Novartis M&A veteran as CBO, signaling an aggressive strategy to advance its groundbreaking iPSC cell therapy for Parkinson's disease.

A bootstrapped AI platform just won an award previously held only by FanDuel and DraftKings. Discover how PlayerProps.ai is changing the game.

Fastest-growing US professional skincare brand HYDRINITY partners with VeraSeaCosmetics, bringing its regenerative science to France's $5.4B beauty scene.

Emerald Cruises names two employees as godparents for its new yacht, Emerald Kaia, signaling a major fleet expansion and a new era of intimate luxury cruising.

With a new CRO and a major retail push, can the values-led organic drink company replicate its foodservice success against CPG giants? We investigate.

A major state investment at Oklahoma State University is set to transform the local food industry, promising safer, fresher products and economic growth.

As the Milano Cortina 2026 Games close, a look at how specialized online academies are revolutionizing training for elite student-athletes.

Thermon Group's $2.2 billion sale to CECO Environmental faces legal scrutiny, leaving shareholders to question if the offer is fair amid record profits.

With a massive Series A, Alveus Therapeutics is advancing novel drugs aiming for more durable and higher-quality weight loss than current blockbusters.

Dr. Frank Smith joins XenoSTART to lead its preclinical unit, aiming to leverage its vast patient-derived model library to speed up oncology drug development.

After a pivotal trial failure, Alector will present its new strategy at a key health conference, focusing on its innovative brain-delivery platform.

NorthX Biologics and Demeetra have partnered to offer a streamlined, royalty-free path from gene to GMP, tackling key bottlenecks for biotech startups.

Leaving the volatile crypto world behind, Cipher Digital is raising billions to build massive data centers for tech giants like AWS and Google.